BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.
| Product | Description | |
|---|---|---|
| Caerulein precursor-related fragment Ec | The source of Caerulein precursor-related fragment Ec is Rana esculenta. This peptide has no sequence similarity with antimicrobial peptides isolated from other species of ranid frogs. It potently and selectively inhibits the growth of the Gram-positive bacterium Escherichia coli (minimal inhibitory concentration (MIC<5 microM)). Synonyms: CPRF-Ec. |  |
| Caffeic-PH | Caffeic-PH is a derivative of caffeic acid that combines with the dipeptide Pro-His. This compound has been reported to exhibit significant antioxidant properties, including free radical scavenging and lipid peroxidation inhibition activity. It is considered to be a powerful antioxidant in both hydrophilic and lipophilic systems, likely due to the structure of proline that enables histidine to effectively donate electrons. The addition of short peptides like Pro-His to caffeic acid is believed to synergistically enhance its antioxidative activity. This enhanced antioxidant activity contributes to the skin-tightening effect by protecting the skin from oxidative stress, which can lead to skin laxity and wrinkles. Therefore, CA-PH can be used as a potent dermal therapeutic agent and a useful cosmetic ingredient for skin tightening and anti-aging purposes. Synonyms: Caffeic acid-Pro-His-NH2; CA-proline-histidine amide; CA-Pro-His-NH2; Caffeoyl-prolyl-histidine amide; 1-[3-(3,4-Dihydroxyphenyl)-1-oxo-2-propen-1-yl]-L-prolyl-L-histidinamide; Coumaroyl(3-OH)-Pro-His-NH2; N-(3-Hydroxycoumaroyl)-L-prolyl-L-histidinamide; (S)-N-((S)-1-Amino-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl)-1-(3-(3,4-dihydroxyphenyl)acryloyl)pyrrolidine-2-carboxamide; CA-PH. Grade: ≥95%. CAS No. 1240406-70-5. Molecular formula: C20H23N5O5. Mole weight: 413.43. | |
| Calcineurin substrate acetate | Calcineurin substrate acetate is a peptide from the regulatory RII subunit of cAMP-dependent protein kinase. Synonyms: H-Asp-Leu-Asp-Val-Pro-Ile-Pro-Gly-Arg-Phe-Asp-Arg-Arg-Val-Ser-Val-Ala-Ala-Glu-OH.CH3CO2H; L-α-Aspartyl-L-leucyl-L-α-aspartyl-L-valyl-L-prolyl-L-isoleucyl-L-prolylglycyl-L-arginyl-L-phenylalanyl-L-α-aspartyl-L-arginyl-L-arginyl-L-valyl-L-seryl-L-valyl-L-alanyl-L-alanyl-L-glutamic acid acetate. Grade: ≥95%. Molecular formula: C94H154N28O31. Mole weight: 2172.40. | |
| Calcitermin | Calcitermin is isolated from Homo sapiens. Calcitermin possesses antifungal activity against C.albicans and is also active against E.coli and P.aeruginosa but not L.monocytogenes and S.aureus. | |
| Calcitonin (20-32), salmon | Calcitonin salmon is a synthetic peptide used to treat osteoporosis and other bone conditions. Synonyms: Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2. Molecular formula: C57H91N19O21. Mole weight: 1378.53. | |
| Calcitonin, eel TFA | It is a peptide hormone produced by the parafollicular C cells of the thyroid or by the ultimobranchial bodies of nonmammalian vertebrates. It is used to regulate calcium homeostasis. Synonyms: Thyrocalcitonin eel (TFA); Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asp-Val-Gly-Ala-Gly-Thr-Pro-NH2.TFA (Disulfide bridge: Cys1-Cys7); L-cysteinyl-L-seryl-L-asparagyl-L-leucyl-L-seryl-L-threonyl-L-cysteinyl-L-valyl-L-leucyl-glycyl-L-lysyl-L-leucyl-L-seryl-L-glutaminyl-L-alpha-glutamyl-L-leucyl-L-histidyl-L-lysyl-L-leucyl-L-glutaminyl-L-threonyl-L-tyrosyl-L-prolyl-L-arginyl-L-threonyl-L-alpha-aspartyl-L-valyl-glycyl-L-alanyl-glycyl-L-threonyl-L-prolinamide (1->7)-disulfide; Eel Thyrocalcitonin TFA. Grade: >98%. Molecular formula: C146H241N43O47S2.C2HF3O2. Mole weight: 3528.89. | |
| Calcitonin gene-related peptide | Calcitonin gene-related peptide is a member of the calcitonin family of peptides consisting of calcitonin, amylin, adrenomedullin, adrenomedullin 2 (intermedin) and calcitonin - receptor - stimulating peptide. Synonyms: Calcitonin, pro-; CALCA protein, human; CALC1 protein, human; CGRP1 protein, human. CAS No. 83652-28-2. Molecular formula: C163H266N50O50S2. Mole weight: 3790.28. | |
| Calcitonin gene-related peptide 1 (16-25) | Calcitonin gene-related peptide 1 (16-25) is a peptide derived from Calcitonin gene-related peptide 1. Calcitonin gene-related peptide 1 dilates a variety of vessels including the coronary, cerebral and systemic vasculature. It also elevates platelet cAMP. Synonyms: Alpha-type CGRP (16-25). | |
| Calcitonin Gene Related Peptide (CGRP) (83-119), rat TFA | α-CGRP (rat) TFA, a member of the calcitonin neuropeptide family, contains 37 amino acids and is an endogenous neuropeptide with vasodilation, cardiovascular, pro-inflammatory and metabolic effects. Synonyms: Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2.TFA (Disulfide bridge: Cys2-Cys7); CGRP-1 (rat) TFA; L-seryl-L-cysteinyl-L-asparagyl-L-threonyl-L-alanyl-L-threonyl-L-cysteinyl-L-valyl-L-threonyl-L-histidyl-L-arginyl-L-leucyl-L-alanyl-glycyl-L-leucyl-L-leucyl-L-seryl-L-arginyl-L-seryl-glycyl-glycyl-L-valyl-L-valyl-L-lysyl-L-alpha-aspartyl-L-asparagyl-L-phenylalanyl-L-valyl-L-prolyl-L-threonyl-L-asparagyl-L-valyl-glycyl-L-seryl-L-alpha-glutamyl-L-alanyl-L-phenylalaninamide (2->7)-disulfide trifluoroacetic acid; α-CGRP (rat) TFA. Grade: >98%. Molecular formula: C162H262N50O52S2.C2HF3O2. Mole weight: 3920.32. | |
| Callinectin | Callinectin is an antibacterial Peptide from Blue Crab. | |
| Calmodulin (58-70) | Calmodulin (58-70) is a fragment of Calmodulin, a calcium-binding protein found in the cytoplasm of all eukaryotic cells. It interacts with many other proteins in the cell, and acts as a regulator or an effector molecule in a wide variety of cellular functions. These functions include things as diverse as regulation of the cell cycle, intracellular signalling, fertilization, and muscle contraction. | |
| Calmodulin Binding Peptide 1 | Calmodulin Binding Peptide 1, a high affinity (pM) CaM-Binding Peptide derived from smooth muscle myosin light chain kinase (MLCK) Peptide, strongly inhibits IP3-induced Ca2+ release. Synonyms: Gly-Val-Met-Pro-Arg-Glu-Glu-Thr-Asp-Ser-Lys-Thr-Ala-Ser-Pro-Trp-Lys-Ser-Ala-Arg-Leu-Met-Val-His-Thr-Val-Ala-Thr-Phe-Asn-Ser-Ile-Lys-Glu-Leu-Asn-Glu-Arg-Trp-Arg-Ser-Leu-Gln-Gln-Leu-Ala. Grade: ≥95%. CAS No. 104041-80-7. Molecular formula: C231H373N69O70S2. Mole weight: 5300.97. | |
| Calmodulin-Dependent Protein Kinase II 281-309 | Calmodulin-Dependent Protein Kinase II 281-309 is the 281-309 amino acid fragment of calcium/calmodulin-dependent protein kinase II (CAM-kinase II). Synonyms: Met-His-Arg-Gln-Glu-Thr-Val-Asp-Cys-Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala-Ile-Leu-Thr-Thr-Met-Leu-Ala; CAM-kinase II 281-309. Grade: ≥95%. CAS No. 116826-37-0. Molecular formula: C146H254N46O39S3. Mole weight: 3374.06. | |
| Cancer related antigens BST-2 (126-134) | Cancer related antigens BST-2 (126-134) is a peptide corresponding to residues 126-134 of BST-2. BST-2 is a unique innate immunity gene with both antiviral and pro-tumor functions and therefore can serve as a paradigm for understanding the roles of other innate immunity genes in cancers. Synonyms: Cancer related antigens Bone marrow stromal antigen 2 (126-134). | |
| Cancer/testis antigen 1 (119-138) | Cancer/testis antigen 1 (119-138) is a 20-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (119-138); Cancer/testis antigen 6.1 (119-138); L antigen family member 2 (119-138). | |
| Cancer/testis antigen 1 (119-143) | Cancer/testis antigen 1 (119-143) is a 25-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (119-143); Cancer/testis antigen 6.1 (119-143); L antigen family member 2 (119-143). | |
| Cancer/testis antigen 1 (121-130) | Cancer/testis antigen 1 (121-130) is a 10-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (121-130); Cancer/testis antigen 6.1 (121-130); L antigen family member 2 (121-130). | |
| Cancer/testis antigen 1 (123-137) | Cancer/testis antigen 1 (123-137) is a 15-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (123-137); Cancer/testis antigen 6.1 (123-137); L antigen family member 2 (123-137). | |
| Cancer/testis antigen 1 (124-134) | Cancer/testis antigen 1 (124-134) is a 11-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (124-134); Cancer/testis antigen 6.1 (124-134); L antigen family member 2 (124-134). | |
| Cancer/testis antigen 1 (124-135) | Cancer/testis antigen 1 (124-135) is a 12-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (124-135); Cancer/testis antigen 6.1 (124-135); L antigen family member 2 (124-135). | |
| Cancer/testis antigen 1 (127-136) | Cancer/testis antigen 1 (127-136) is a 10-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (127-136); Cancer/testis antigen 6.1 (127-136); L antigen family member 2 (127-136). | |
| Cancer/testis antigen 1 (139-156) | Cancer/testis antigen 1 (139-156) is a 18-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (139-156); Cancer/testis antigen 6.1 (139-156); L antigen family member 2 (139-156). | |
| Cancer/testis antigen 1 (53-62) | Cancer/testis antigen 1 (53-62) is a 10-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (53-62); Cancer/testis antigen 6.1 (53-62); L antigen family member 2 (53-62). | |
| Cancer/testis antigen 1 (60-72) | Cancer/testis antigen 1 (60-72) is a 13-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (60-72); Cancer/testis antigen 6.1 (60-72); L antigen family member 2 (60-72). | |
| Cancer/testis antigen 1 (80-88) | Cancer/testis antigen 1 (80-88) is a 9-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (80-88); Cancer/testis antigen 6.1 (80-88); L antigen family member 2 (80-88). | |
| Cancer/testis antigen 1 (86-97) | Cancer/testis antigen 1 (86-97) is a 12-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (86-97); Cancer/testis antigen 6.1 (86-97); L antigen family member 2 (86-97). | |
| Cancer/testis antigen 1 (87-100) | Cancer/testis antigen 1 (87-100) is a 14-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (87-100); Cancer/testis antigen 6.1(87-100); L antigen family member 2 (87-100). | |
| Cancer/testis antigen 1 (87-111) | Cancer/testis antigen 1 (87-111) is a 25-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (87-111); Cancer/testis antigen 6.1 (87-111); L antigen family member 2 (87-111). | |
| Cancer/testis antigen 1 (89-100) | Cancer/testis antigen 1 (89-100) is a 12-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (89-100); Cancer/testis antigen 6.1 (89-100); L antigen family member 2 (89-100). | |
| Cancer/testis antigen 1 (91-101) | Cancer/testis antigen 1 (91-101) is a 11-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (91-101); Cancer/testis antigen 6.1 (91-101); L antigen family member 2 (91-101). | |
| Cancer/testis antigen 1 (92-100) | Cancer/testis antigen 1 (92-100) is a 9-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (92-100); Cancer/testis antigen 6.1 (92-100); L antigen family member 2 (92-100). | |
| Cancer/testis antigen 1 (94-102) | Cancer/testis antigen 1 (94-102) is a 9-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (94-102); Cancer/testis antigen 6.1 (94-102); L antigen family member 2 (94-102). | |
| Cancer/testis antigen 1 (95-107) | Cancer/testis antigen 1 (95-107) is a 13-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (95-107); Cancer/testis antigen 6.1 (95-107); L antigen family member 2 (95-107). | |
| Cancer/testis antigen 1 (96-104) | Cancer/testis antigen 1 (96-104) is a 9-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (96-104); Cancer/testis antigen 6.1 (96-104); L antigen family member 2 (96-104). | |
| Cancer/testis antigen 1 (ORF2 (14-33)) | Cancer/testis antigen 1 (ORF2 (14-33)) is a 20-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (ORF2 (14-33)); Cancer/testis antigen 6.1 (ORF2 (14-33)); L antigen family member 2 (ORF2 (14-33)). | |
| Cancer/testis antigen 1 (ORF2 (18-27)) | Cancer/testis antigen 1 (ORF2 (18-27)) is a 10-aa peptide. Cancer/testis antigen 1 is an archetypical example of a CTA with restricted expression to germ cells and placental cells and re-expression in tumor cells. Synonyms: NY-ESO-1 (ORF2 (18-27)); Cancer/testis antigen 6.1 (ORF2 (18-27)); L antigen family member 2 (ORF2 (18-27)). | |
| Cancer/testis antigen 2 (103-111) | Cancer/testis antigen 2 (103-111) is amino acids 103 to 111 fragment of Cancer/testis antigen 2. This protein is expressed in a wide array of cancers including melanoma, breast cancer, bladder cancer and prostate cancer. Synonyms: Autoimmunogenic cancer/testis antigen NY-ESO-2 (103-111); Cancer/testis antigen 6.2 (103-111); L antigen family member 1 (103-111). | |
| Cancer/testis antigen 2 (108-120) | Cancer/testis antigen 2 (108-120) is amino acids 108 to 120 fragment of Cancer/testis antigen 2. This protein is expressed in a wide array of cancers including melanoma, breast cancer, bladder cancer and prostate cancer. Synonyms: Autoimmunogenic cancer/testis antigen NY-ESO-2 (108-120); Cancer/testis antigen 6.2 (108-120); L antigen family member 1 (108-120). | |
| Cancer/testis antigen 2 (37-50) | Cancer/testis antigen 2 (37-50) is amino acids 37 to 50 fragment of Cancer/testis antigen 2. This protein is expressed in a wide array of cancers including melanoma, breast cancer, bladder cancer and prostate cancer. Synonyms: Autoimmunogenic cancer/testis antigen NY-ESO-2 (37-50); Cancer/testis antigen 6.2 (37-50); L antigen family member 1 (37-50). | |
| Cancer/testis antigen 2 (ORF2 (1-11)) | Cancer/testis antigen 2 (ORF2 (1-11)) is a bioactive peptide of Cancer/testis antigen 2. This protein is expressed in a wide array of cancers including melanoma, breast cancer, bladder cancer and prostate cancer. Synonyms: Autoimmunogenic cancer/testis antigen NY-ESO-2 (ORF2 (1-11)); Cancer/testis antigen 6.2 (ORF2 (1-11)); L antigen family member 1 (ORF2 (1-11)). | |
| Candida Albicans alpha factor | Candida Albicans alpha factor. Synonyms: Gly-Phe-Arg-Leu-Thr-Asn-Phe-Gly-Tyr-Phe-Glu-Pro-Gly. Molecular formula: C72H97N17O19. Mole weight: 1504.70. | |
| Canine beta-defensin | Canine beta-defensin is isolated from Canis lupus familiaris. It has antibacterial and antifungal activity. | |
| Capistruin | Capistruin is isolated from Burkholderia thailandensis E264. It exhibits antimicrobial activity against closely related Burkholderia and Pseudomonas strains. | |
| Caprooyl Tetrapeptide-3 | Caprooyl Tetrapeptide-3 is a synthetically derived peptide that is used in skincare to help improve the visible signs of aging. It is known for its ability to stimulate the expression of collagen VII and laminin-5, which are crucial for maintaining the integrity of the dermal-epidermal junction (DEJ) and providing firmness to the skin. This peptide is also recognized for its potential to reduce the appearance of fine lines and wrinkles by enhancing the synthesis of these structural proteins. It is used for skin repair. Synonyms: L-Lysinamide, N2-(1-oxohexyl)-L-lysylglycyl-L-histidyl-; N2-(1-Oxohexyl)-L-lysylglycyl-L-histidyl-L-lysinamide; Caprooyl-Lys-Gly-His-Lys-NH2; L-Lysyl-N-hexanoylglycyl-L-histidyl-L-lysinamide; N-Hexanoyl-L-lysyl-glycyl-L-histidyl-L-lysinamide; Hexanoyl-Lys-Gly-His-Lys-NH2; KGHK; (S)-6-Amino-N-(2-(((S)-1-(((S)-1,6-diamino-1-oxohexan-2-yl)amino)-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl)amino)-2-oxoethyl)-2-hexanamidohexanamide. Grade: ≥95%. CAS No. 1012317-70-2. Molecular formula: C26H47N9O5. Mole weight: 565.71. | |
| Carbamoyl-Asp-OH · magnesium salt/Carbamoyl-Asp-OH · dipotassium salt (1:1) | Carbamoyl-Asp-OH · magnesium salt/Carbamoyl-Asp-OH · dipotassium salt (1:1). Synonyms: Carbamoyl-Asp-OH magnesium salt/Carbamoyl-Asp-OH dipotassium salt (1:1). CAS No. 13184-27-5. Molecular formula: C10H12K2MgN4O10. Mole weight: 450.73. | |
| Carbobenzoxyhydrazide hydrochloride | Carbobenzoxyhydrazide hydrochloride. Synonyms: Z-NHNH2 HCl; Z-hydrazide HCl; Benzyl carbazate hydrochloride. Grade: 95+%. CAS No. 2540-62-7. Molecular formula: C8H11ClN2O2. Mole weight: 202.64. | |
| Carbonic acid di-2-pyridyl ester | Carbonic acid di-2-pyridyl ester is used as a coupling agent in the esterification of carboxylic acids. Di-2-pyridyl carbonate is also used as a reagent to synthesize active carbonates and carbamates. Synonyms: DPC; 2-Pyridinol-2,2'-carbonate; 2-Pyridinol Carbonate; Bis(pyrid-2-yl) Carbonate; Bis(pyridin-2-yl) Carbonate; Di-2-pyridyl Carbonate; 2-Pyridinol, carbonate (2:1) (ester) (9CI); Carbonic acid, di-2-pyridyl ester (7CI,8CI). Grade: 98 % (HPLC). CAS No. 1659-31-0. Molecular formula: C11H8N2O3. Mole weight: 216.19. | |
| Carbonic anhydrase 9 (254-262) | Carbonic anhydrase 9 (254-262) is a peptide corresponding to residues 254-262 of Carbonic anhydrase 9. Carbonic anhydrase 9 has been correlated with progression and survival in patients with renal cell carcinoma (RCC). Synonyms: Carbonic anhydrase IX (254-262); CAIX (254-262). | |
| Carboxylic acid functionalized polyethyleneglycol resin, High Load | TentaGel resins are grafted copolymers consisting of a low crosslinked polystyrene matrix on which poly(ethylene glycol) (PEG or POE) is grafted. Synonyms: COOH-PEG Resin, HL; TentaGel HL COOH; High loaded TentaGel carboxy resin. | |
| Carboxylic acid functionalized polyethyleneglycol resin (macro beads) | TentaGel resins are grafted copolymers consisting of a low crosslinked polystyrene matrix on which poly(ethylene glycol) (PEG or POE) is grafted. Synonyms: COOH-PEG-Macro Resin; TentaGel MB COOH; Macrobead TentaGel carboxy resin. | |
| Carboxypolystyrene | Carboxypolystyrene can be used for the solid phase immobilization of amines, alcohols and phenols. Synonyms: Polystyrene carboxylic acid. | |
| Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 | Diseases associated with CTDSP2 include Acute Tympanitis and Myringitis Bullosa Hemorrhagica. Among its related pathways are Signaling by BMP and Metabolism of proteins. Synonyms: Nuclear LIM interactor-interacting factor 2. | |
| Carcinine dihydrochloride | Carcinine is a natural peptide derivative. Carcinine dihydrochloride has been used to study its effects on dopaminergic neuron degeneration. It has antioxidant and anti-saccharification functions and has better stability because it is not recognized by enzymes in the body and loses activity. It can be used to remove skin yellow, lighten skin tone, fight against the invasion of external ultraviolet rays and pollutants and other adverse environment on the skin, prevent skin premature aging, maintain skin young state, can be added to beauty care products, such as emulsion, mask, morning, night cream, eye cream, eye serum, facial essence, muscle base liquid, toner, eye mask, gel and so on. Synonyms: Propanamide, 3-amino-N-[2-(1H-imidazol-5-yl)ethyl]-, hydrochloride (1:2); Propanamide, 3-amino-N-[2-(1H-imidazol-4-yl)ethyl]-, dihydrochloride; Alistin dihydrochloride; Decarboxycarnosine dihydrochloride; β-Alanylhistamine dihydrochloride; Decarboxy carnosine hydrochloride; Decarboxy Carnosine HCL. Grade: >95%. CAS No. 57022-38-5. Molecular formula: C8H16Cl2N4O. Mole weight: 255.14. | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (116-140) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Synonyms: CEACAM5 (116-140); Cluster of Differentiation 66e (116-140). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (268-277) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Synonyms: CEACAM5 (268-277); Cluster of Differentiation 66e (268-277). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (355-367) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Synonyms: CEACAM5 (355-367); Cluster of Differentiation 66e (355-367). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (425-437) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Synonyms: CEACAM5 (425-437); Cluster of Differentiation 66e (425-437). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (568-582) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Synonyms: CEACAM5 (568-582); Cluster of Differentiation 66e (568-582). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (605-613) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Synonyms: CEACAM5 (605-613); Cluster of Differentiation 66e (605-613). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (61-69) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Synonyms: CEACAM5 (61-69); Cluster of Differentiation 66e (61-69). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (625-639) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Synonyms: CEACAM5 (625-639); Cluster of Differentiation 66e (625-639). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (652-660) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Synonyms: CEACAM5 (652-660); Cluster of Differentiation 66e (652-660). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (653-667) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Synonyms: CEACAM5 (653-667); Cluster of Differentiation 66e (653-667). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (666-678) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Synonyms: CEACAM5 (666-678); Cluster of Differentiation 66e (666-678). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (691-699) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Synonyms: CEACAM5 (691-699); Cluster of Differentiation 66e (691-699). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (694-702) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Synonyms: CEACAM5 (694-702); Cluster of Differentiation 66e (694-702). | |
| Carcinoembryonic antigen-related cell adhesion molecule 5 (99-111) | A peptide fragment of Carcinoembryonic antigen-related cell adhesion molecule 5. CEACAM5 is a member of the carcinoembryonic antigen (CEA) gene family. Synonyms: CEACAM5 (99-111); Cluster of Differentiation 66e (99-111). | |
| Cardiotoxin Analog (CTX) IV 6-12 | Cardiotoxin Analog (CTX) IV (6-12) is the 6-12 amino acid fragment of CTX IV, which is a unique snake venom cardiotoxin. Synonyms: Leu-Ile-Pro-Pro-Phe-Trp-Lys-NH2; L-leucyl-L-isoleucyl-L-prolyl-L-prolyl-L-phenylalanyl-L-tryptophyl-L-lysinamide; Naja mossambica mossambica alpha-neurotoxin I. Grade: ≥95%. CAS No. 115722-23-1. Molecular formula: C48H70N10O7. Mole weight: 899.13. | |
| Cardiotoxin Analog (CTX) IV (6-12) TFA | Cardiotoxin Analog (CTX) IV (6-12) is the 6-12 amino acid fragment of CTX IV, which is a unique snake venom cardiotoxin. CAS No. 2918768-05-3. Molecular formula: C50H71F3N10O9. Mole weight: 1013.16. | |
| Carnobacteriocin B2 | Carnobacteriocin B2 is an antimicrobial isolated from Carnobacterium maltaromaticum. Synonyms: Bacteriocin carnobacteriocin B2; CbnB2. Molecular formula: C40H62N12O15S. Mole weight: 983.1. | |
Our database is helping our users find suppliers everyday.
